# OnCo record idea-cost-voluntary-licensing-oncology (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-cost-voluntary-licensing-oncology/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-cost-voluntary-licensing-oncology" ;
  schema:name "Voluntary licences and price caps for patented cancer drugs in low-income countries"@en ;
  schema:description "India's 2012 compulsory licence on sorafenib cut its price by about 97% and its 2019 cap on trade margins lowered the shelf price of 42 cancer drugs; voluntary licences through a patent pool would achieve the same without a fight."@en ;
  schema:url <https://onco.cc/ideas/idea-cost-voluntary-licensing-oncology/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://medicinespatentpool.org/>, <https://web.archive.org/web/20250708090325/http://www.nppaindia.nic.in/>, <https://ipindia.gov.in/> ;
  onco:drugs <https://onco.cc/drugs/sorafenib/>, <https://onco.cc/drugs/imatinib/> ;
  onco:institutions <https://onco.cc/institutions/who/>, <https://onco.cc/institutions/cdsco/> ;
  onco:terms <https://onco.cc/terms/who-essential-medicines/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-global-access/>, <https://onco.cc/bottlenecks/b-drug-pricing/>, <https://onco.cc/bottlenecks/b-ip-collaboration/> .